News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Study Demonstrates That Muscular Counterpulsation — The Basis Of Cardiola's M.Pulse(R) System — Is "Safe And Efficient For Improving Cardiac Function" Non-Surgically In Patients With Coronary Artery Disease (CAD)



6/23/2009 10:09:47 AM

WINTERTHUR, Switzerland--(BUSINESS WIRE)--Cardiola AG announced today that data from a study (“Safety and efficacy of ECG-triggered muscular counterpulsation for hemodynamic improvement of cardiac function”) presented at the recently convened Annual Congress of the Swiss Society of Cardiology demonstrates that “MCP (muscular counterpulsation) is safe and efficient for improving cardiac function in patients with coronary artery disease (CAD). One of the study’s investigators was Prof. Beat Walpoth, Director of Cardiovascular Research, Clinical and Experimental, at University Hospital in Geneva, Switzerland.

Read at BioSpace.com


comments powered by Disqus
Cardiola
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES